細胞溶解/細胞分画の世界市場規模：細胞タイプ別、エンドユーザー別、製品別、地域別、範囲および予測

細胞溶解/細胞分画の市場規模と予測

細胞溶解/細胞分画市場規模は、2023年に45億5,000万米ドルと評価され、2024年から2030年にかけてCAGR 7.2%で拡大し、2030年には63億米ドルに達すると予測されています。同市場の成長は、商業的診断および分析用途に使用される培養細胞手順の数が増加していることに起因しています。様々な疾患の有病率の継続的な上昇と新規治療に対する需要が、予測期間を通じて市場拡大を促進すると予測されます。加えて、細胞生物学研究の進展と、様々な慢性および非慢性疾患の有病率の増加によるタンパク質分析の需要の増加は、市場の成長にプラスの影響を与えると予想されます。

世界の細胞溶解/細胞分画市場の定義

細胞溶解/細胞分画は、細胞生物学において細胞やその成分を開いて分離するために応用される関連技術です。細胞溶解は、核酸、タンパク質、細胞小器官のような細胞内の成分を放出するために細胞を壊すことを指します。細胞の開放は、化学的、機械的、または酵素的に行われます。細胞溶解は、医薬品開発、タンパク質の精製、DNAの単離など、いくつかの研究用途において不可欠なステップです。

細胞分画とは、溶解後の細胞の異なる成分を分離することです。このプロセスは、密度勾配遠心分離、示差遠心分離、および細胞内または特定のオルガネラを単離するその他の方法によって行われます。得られた物質の分画は、さらなる分析に使用することができます。

細胞溶解/細胞分画の世界市場概要

人口の間で個別化医療に対する需要が高まっていることが、市場の主要促進要因です。個別化医療は、オーダーメイドの治療、病気の早期発見、ヘルスケアコストの削減、医薬品開発の改善、より効率的な臨床試験など、いくつかの利点を提供します。個別化医療は、ヘルスケア専門家が患者に合わせた治療を提供することを可能にします。治療はライフスタイル、特定の遺伝的体質、その他の要因に基づいて行われます。これらの要因は、治療結果を改善し、薬剤の副作用リスクを軽減するのに役立ちます。細胞溶解は、患者の治療や診断に関連する特定の分子や細胞タイプを抽出・分離する個別化医療に応用されています。

ライフサイエンス研究のための公的・民間機関による投資の増加は、市場成長にプラスの影響を与えると予想されます。たとえば、2023年3月に英国政府は2億7,700万ポンドの資金提供を発表し、そのうち政府が1,700万ポンドを拠出する予定です。残りの2億6,000万ポンドは、ライフサイエンス製造プロジェクト、環境への影響の最小化、健康回復力の強化、イノベーションの展開のための民間投資を通じて提供され、国の成長に貢献します。この資金援助により、全国で500人以上の雇用が創出され、同国の経済を支えることが期待されます。

さらに、がん、糖尿病、心血管疾患、関節炎などの慢性疾患の有病率の増加は、市場の成長にプラスの影響を与えると予想されます。細胞溶解と分画は、慢性疾患の診断に用いられる重要なステップです。例えば、関節リウマチなどの自己免疫疾患の診断では、患者の血液から自己免疫細胞を分離し、遺伝子発現解析のためにDNAまたはRNAを抽出するために細胞溶解を使用することができます。このステップでは、免疫細胞で過剰発現または過小発現している特定のタンパク質や遺伝子を特定することができ、病気の診断や個別化医療の開発に役立ちます。

目次

第1章 世界の細胞溶解/細胞分画市場のイントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 細胞溶解／細胞分画の世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 細胞溶解／細胞分画の世界市場：細胞タイプ別

• 概要
• 哺乳類細胞
• 微生物細胞
• その他

第6章 細胞溶解/細胞分画の世界市場：エンドユーザー別

• 概要
• 研究機関および研究所
• バイオ医薬品・バイオテクノロジー企業
• その他

第7章 細胞溶解／細胞分画の世界市場：製品別

• 概要
• 機器
  • ソニケーター
  • ホモジナイザー
  • その他の装置
• 消耗品
  • 試薬とキット
  • ビーズ
  • 消耗品

第8章 細胞溶解／細胞分画の世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
  • その他のラテンアメリカ
• 中東・アフリカ
  • アラブ首長国連邦
  • サウジアラビア
  • 南アフリカ
  • その他中東とアフリカ

第9章 世界の細胞溶解/細胞分画市場：競合情勢

• 概要
• 各社の市場ランキング
• 主な開発戦略
• 企業の地域別フットプリント
• 企業の産業別フットプリント
• ACEマトリックス

第10章 企業プロファイル

• Thermo Fisher Scientific Inc.
• Merck KGAA
• Bio-Rad Laboratories, Inc.
• Beckman Coulter, Inc.
• Becton, Dickinson, and Company
• Cell Signaling Technology, Inc.
• MiltenyiBiotec
• Roche Diagnostics
• Qiagen N.V.
• Qsonica, LLC

第11章 主な発展

• 製品の上市／開発
• 合併と買収
• 事業拡大
• パートナーシップと提携

第12章 付録

• 関連調査

Cell Lysis/Cell Fractionation Market Size And Forecast

Cell Lysis/Cell Fractionation Market size was valued at USD 4.55 Billion in 2023 and is calculated to reach USD 6.3 Billion by 2030, expanding at a CAGR of 7.2% from 2024 to 2030. The market's growth is attributed to the growing number of cultured cell procedures used for commercial diagnostic and analytical applications. The continued rise in the prevalence of various ailments and the demand for novel therapies are projected to drive market expansion throughout the forecast period. Additionally, the growing advances in cell biology research and increased demand for protein analysis due to the increasing prevalence of various chronic and non-chronic conditions are expected to positively influence the market's growth.

Global Cell Lysis/Cell Fractionation Market Definition

Cell lysis and fractionation are related techniques that have applications in cell biology to open and separate cells and their components. Cell lysis refers to breaking the cells open to release the components in the cell, such as nucleic acid, proteins, and cell organelles. The cell's opening is done chemically, mechanically, or enzymatically. Cell lysis is an essential step in several research applications, such as drug development, protein purification, and DNA isolation.

Cell fractionation refers to separating different components of the cell after lysis. The process is carried out through density gradient centrifugation, differential centrifugation, and other methods to isolate subcellular or specific organelles. The fractions of the obtained materials can then be used for further analysis.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Cell Lysis/Cell Fractionation Market Overview

The growing demand for personalized medicine among the population is a key driver for the market. Personalized medicine offers several advantages, such as tailored treatments, early disease detection, reduced healthcare costs, improved drug development, and more efficient clinical trials. Personalized medicines allow healthcare professionals to provide tailored treatment to patients. The treatment is based on lifestyle, specific genetic makeup, and other factors; these factors help to improve the treatment outcomes and reduce the risk of side effects of the drugs. Cell lysis has applications in personalized medicines for extracting and isolating specific molecules or cell types relevant to a patient's treatment and diagnosis.

Growing investments by public and private institutions for research in life sciences are anticipated to impact market growth positively. For instance, in March 2023, the UK government announced funding of GBP 277 Million, wherein the government will contribute GBP 17 Million. The remaining 260 million will be provided through private investments for life science manufacturing projects, minimizing environmental impact, boosting health resilience, and deploying innovations, contributing to the country's growth. The funding is anticipated to support the country's economy by providing more than 500 jobs nationwide.

Additionally, the increasing prevalence of chronic conditions such as cancer, diabetes, cardiovascular diseases, and arthritis, among others, is expected to impact the market growth positively. Cell lysis and fractionation are key steps used to diagnose chronic conditions. For example, diagnosis of autoimmune diseases such as rheumatoid arthritis and cell lysis can be used to isolate autoimmune cells from the patient's blood and extract the DNA or RNA for gene expression analysis. The step helps identify specific proteins and genes that are either over or under-expressed in the immune cells, helping diagnose the disease and develop personalized medicine.

Global Cell Lysis/Cell Fractionation Market: Segmentation Analysis

The Global Cell Lysis/Cell Fractionation Market is Segmented on the basis of Type Of Cell, End User, Product, and Geography.

Cell Lysis/Cell Fractionation Market, By Type Of Cell

• Mammalian Cells
• Microbial Cells
• Others

Based on Type Of Cell, the market is bifurcated into Mammalian Cells, Microbial Cells, and Others. The mammalian cells segment accounted for the highest share in 2022 and is calculated to grow lucratively during the forecast period. The applications of these cells for the bio-manufacturing of vaccines, therapeutic proteins, and other recombinant products are key factors driving the segment's growth.

Cell Lysis/Cell Fractionation Market, By End User

• Research Laboratories and Institutes
• Biopharmaceutical and Biotechnology Companies
• Others

Based on End User, the market is bifurcated into Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, and Others. The Research Laboratories and Institutes segment held the largest market share in 2022 and is calculated to grow lucratively during the forecast period. The growing number of biotechnology institutes and many research activities undertaken by these institutes are driving the market's growth.

Cell Lysis/Cell Fractionation Market, By Product

• Instruments
• Sonicator
• Homogenizers
• Other Instruments
• Consumables
• Reagents and Kits
• Beads
• Disposables

Based on Product, the market is bifurcated into Instruments and Consumables. Instruments are classified into sonicators, homogenizers, and other instruments. Consumables are further differentiated into reagents & kits, beads, and disposables. The consumables segment accounted for the highest share in 2022 and is projected to grow lucratively during the forecast period. Repeated purchases, increased funding for cell-based research activities, and the increasing instances of chronic conditions among the population are factors driving the segment's growth.

Cell Lysis/Cell Fractionation Market, By Geography

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America
• On the basis of Regional Analysis, The Global Cell Lysis/Cell Fractionation Market is classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. North America held the highest share in 2022 and is projected to grow lucratively during the forecast period owing to the technologically advanced R&D infrastructure. Moreover, the regional governments are also providing funding for the development of infrastructure and research projects, which is expected to impact market growth positively.

Key Players

• The "Global Cell Lysis/Cell Fractionation Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Thermo Fisher Scientific Inc., Merck KGAA, Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, Cell Signaling Technology, Inc., MiltenyiBiotec, Roche Diagnostics, Qiagen N.V., and Qsonica, LLC., among others.
• This section provides a company overview, ranking analysis, company regional and industry footprint, and ACE Matrix.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Key Developments

• In November 2022, Merck announced it would acquire Imago BioSciences Inc. The acquisition will help Merck to gain an edge over its competitors for clinical development.
• Ace Matrix Analysis
• The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as
• Active, Cutting Edge, Emerging, and Innovators.
• Market Attractiveness
• The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Cell Lysis/Cell Fractionation Market. We cover the major impacting factors driving the industry growth in the given region.
• Porter's Five Forces
• The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global Cell Lysis/Cell Fractionation Market, gauge the attractiveness of a particular sector, and assess investment possibilities.

TABLE OF CONTENTS

1 INTRODUCTION OF THE GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porter's Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET, BY TYPE OF CELL

• 6.1 Overview
• 6.2 Mammalian Cells
• 6.3 Microbial Cells
• 6.4 Others

6 GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET, BY END USER

• 7.1 Overview
• 7.2 Research Laboratories and Institutes
• 7.3 Biopharmaceutical and Biotechnology Companies
• 7.4 Others

7 GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET, BY PRODUCT

• 7.1 Overview
• 7.2 Instruments
  • 7.2.1 Sonicator
  • 7.2.2 Homogenizers
  • 7.2.3 Other Instruments
• 7.3 Consumables
  • 7.3.1 Reagents and Kits
  • 7.3.2 Beads
  • 7.3.3 Disposables

8 GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 The U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 The U.K.
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Argentina
  • 8.5.3 Rest of LATAM
• 8.6 Middle East and Africa
  • 8.6.1 UAE
  • 8.6.2 Saudi Arabia
  • 8.6.3 South Africa
  • 8.6.4 Rest of the Middle East and Africa

9 GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies
• 9.4 Company Regional Footprint
• 9.5 Company Industry Footprint
• 9.6 ACE Matrix

10 COMPANY PROFILES

• 10.1 Thermo Fisher Scientific Inc.
  • 10.1.1 Company Overview
  • 10.1.2 Company Insights
  • 10.1.3 Business Breakdown
  • 10.1.4 Product Benchmarking
  • 10.1.5 Key Developments
  • 10.1.6 Winning Imperatives
  • 10.1.7 Current Focus & Strategies
  • 10.1.8 Threat from Competition
  • 10.1.9 SWOT Analysis
• 10.2 Merck KGAA
  • 10.2.1 Company Overview
  • 10.2.2 Company Insights
  • 10.2.3 Business Breakdown
  • 10.2.4 Product Benchmarking
  • 10.2.5 Key Developments
  • 10.2.6 Winning Imperatives
  • 10.2.7 Current Focus & Strategies
  • 10.2.8 Threat from Competition
  • 10.2.9 SWOT Analysis
• 10.3 Bio-Rad Laboratories, Inc.
  • 10.3.1 Company Overview
  • 10.3.2 Company Insights
  • 10.3.3 Business Breakdown
  • 10.3.4 Product Benchmarking
  • 10.3.5 Key Developments
  • 10.3.6 Winning Imperatives
  • 10.3.7 Current Focus & Strategies
  • 10.3.8 Threat from Competition
  • 10.3.9 SWOT Analysis
• 10.4 Beckman Coulter, Inc.
  • 10.4.1 Company Overview
  • 10.4.2 Company Insights
  • 10.4.3 Business Breakdown
  • 10.4.4 Product Benchmarking
  • 10.4.5 Key Developments
  • 10.4.6 Winning Imperatives
  • 10.4.7 Current Focus & Strategies
  • 10.4.8 Threat from Competition
  • 10.4.9 SWOT Analysis
• 10.5 Becton, Dickinson, and Company
  • 10.5.1 Company Overview
  • 10.5.2 Company Insights
  • 10.5.3 Business Breakdown
  • 10.5.4 Product Benchmarking
  • 10.5.5 Key Developments
  • 10.5.6 Winning Imperatives
  • 10.5.7 Current Focus & Strategies
  • 10.5.8 Threat from Competition
  • 10.5.9 SWOT Analysis
• 10.6 Cell Signaling Technology, Inc.
  • 10.6.1 Company Overview
  • 10.6.2 Company Insights
  • 10.6.3 Business Breakdown
  • 10.6.4 Product Benchmarking
  • 10.6.5 Key Developments
  • 10.6.6 Winning Imperatives
  • 10.6.7 Current Focus & Strategies
  • 10.6.8 Threat from Competition
  • 10.6.9 SWOT Analysis
• 10.7 MiltenyiBiotec
  • 10.7.1 Company Overview
  • 10.7.2 Company Insights
  • 10.7.3 Business Breakdown
  • 10.7.4 Product Benchmarking
  • 10.7.5 Key Developments
  • 10.7.6 Winning Imperatives
  • 10.7.7 Current Focus & Strategies
  • 10.7.8 Threat from Competition
  • 10.7.9 SWOT Analysis
• 10.8 Roche Diagnostics
  • 10.8.1 Company Overview
  • 10.8.2 Company Insights
  • 10.8.3 Business Breakdown
  • 10.8.4 Product Benchmarking
  • 10.8.5 Key Developments
  • 10.8.6 Winning Imperatives
  • 10.8.7 Current Focus & Strategies
  • 10.8.8 Threat from Competition
  • 10.8.9 SWOT Analysis
• 10.9 Qiagen N.V.
  • 10.9.1 Company Overview
  • 10.9.2 Company Insights
  • 10.9.3 Business Breakdown
  • 10.9.4 Product Benchmarking
  • 10.9.5 Key Developments
  • 10.9.6 Winning Imperatives
  • 10.9.7 Current Focus & Strategies
  • 10.9.8 Threat from Competition
  • 10.9.9 SWOT Analysis
• 10.10 Qsonica, LLC
  • 10.10.1 Company Overview
  • 10.10.2 Company Insights
  • 10.10.3 Business Breakdown
  • 10.10.4 Product Benchmarking
  • 10.10.5 Key Developments
  • 10.10.6 Winning Imperatives
  • 10.10.7 Current Focus & Strategies
  • 10.10.8 Threat from Competition
  • 10.10.9 SWOT Analysis

11 KEY DEVELOPMENTS

• 11.1 Product Launches/Developments
• 11.2 Mergers and Acquisitions
• 11.3 Business Expansions
• 11.4 Partnerships and Collaborations

12 Appendix

Related Research